BIOMAT Database Logo BIOMAT Database Logo

Alterations in T cell receptor and signal transduction molecules in melanoma patients. 1995

A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
Immunotherapy Laboratory, Applications International Corporation, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702-1201, USA.

We have recently described molecular changes in T cells from tumor-bearing patients that are associated with depressed immune function. The present work investigates changes in T-cell signal transduction proteins including the T-cell receptor-zeta (TCR-zeta) chain and receptor-associated tyrosine kinases in patients with metastatic malignant melanoma. A marked decrease in the expression of the TCR-zeta chain was observed in the peripheral blood T cells of 19 (43%) of 44 patients. Decreases in several tyrosine kinases were found in 12 (57%) of 21 patients tested. T cells from patients with diminished TCR-zeta chain expression also showed statistically significant differences in cytokine production pattern, with lower interleukin 2 and IFN-zeta production compared with normal subjects and melanoma patients with normal TCR-zeta chain status. The overall survival of melanoma patients with low TCR-zeta chain expression was significantly shorter than that of patients with normal TCR-zeta chain expression (P = 0.0013). TCR-zeta-deficient patients showed a trend toward having faster growing tumors. There was no correlation between the pretreatment TCR-zeta chain status and albumin or performance status. These findings suggest that alterations in T-cell function occur commonly in melanoma patients and may be independent predictors of clinical outcome.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
[T cell receptor and its related molecules in signal transduction].
February 1999, Nihon rinsho. Japanese journal of clinical medicine,
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
Alterations in T-cell signal transduction molecules associated with recurrent spontaneous pregnancy loss.
October 2004, Journal of reproductive immunology,
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
Phase separation of signaling molecules promotes T cell receptor signal transduction.
April 2016, Science (New York, N.Y.),
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
T cell Receptor Signal Transduction in T lymphocytes.
October 2012, Journal of clinical & cellular immunology,
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
T-cell antigen receptor signal transduction.
April 2002, Immunology,
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
T cell antigen receptor signal transduction.
April 1997, Current opinion in cell biology,
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
T cell antigen-receptor signal transduction.
June 1999, Current opinion in immunology,
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
T-cell receptor isoforms and signal transduction.
February 1991, Current opinion in immunology,
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
T cell accessory molecules mediating cell adhesion and signal transduction.
October 1989, Current opinion in immunology,
A H Zea, and B D Curti, and D L Longo, and W G Alvord, and S L Strobl, and H Mizoguchi, and S P Creekmore, and J J O'Shea, and G C Powers, and W J Urba
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.
December 1992, Science (New York, N.Y.),
Copied contents to your clipboard!